A potential COVID-19 vaccine being developed by Pfizer and BioNTech has been found to be more than 90% effective.
The vaccine has been tested on more than 43,500 participants during Phase 3 — the final stage of development when it is given to thousands to test its efficacy and safety.
Analysis carried out evaluated that 94 trial participants had been confirmed to have contracted COVID-19.
"Today is a great day for science and humanity," Pfizer Chairman and CEO, Dr Albert Bourla, said in a statement.
Read more at:
Coronavirus: Our COVID-19 vaccine is 90% effective, says Pfizer | Euronews